After abandoning its first initial public offering (IPO) filed in 2021, natural killer (NK) cell therapy specialist Artiva ...

Novo Nordisk's parent company Novo Holdings has led a $100 million third-round financing for Swiss biotech Asceneuron, which ...

Clinical trials are strictly regulated to ensure patient safety, but the current framework in the UK is stifling early-phase ...

A digital test that will help to provide a faster diagnosis for people with attention deficit hyperactivity disorder (ADHD) ...

Vision loss associated with diabetes is one of the more prevalent and growing healthcare burdens in the Western world. In today’s podcast, web editor Nicole Raleigh welcomes Dr Catherine Beech, CEO of ...